ARLINGTON, Va.– The National Association of Chain Drug Stores (NACDS) is among the 13 health care entities urging Congress to ensure that the Centers for Medicare & Medicaid Services (CMS) adheres to the January 1, 2022 deadline for compliance with the electronic prescribing of controlled substances (EPCS) requirement. In a letter, NACDS and allied organizations urge
ARLINGTON, Va. — NACDS is urging the federal Centers for Medicare & Medicaid Services (CMS) to fix yet another unworkable situation for pharmacies and for the patients who rely on them. In a letter, NACDS explains that while prescription drug discount cards help to reduce patients’ out-of-pocket costs, states are using data from these transactions in a way that is inconsistent with federal law and policy, and that drives down reimbursement to pharmacies for prescriptions that they fill in
ARLINGTON, Va. — NACDS, the Washington State Pharmacy Association (WSPA) and the National Community Pharmacists Association (NCPA) filed an important legal brief last week in support of the Centers for Medicare & Medicaid Services’ (CMS) rejection of Washington State’s below-cost reimbursement of community pharmacies providing care and services to Medicaid patients, as inconsistent with federal
ARLINGTON, Va. — Each NACDS member company has a powerful opportunity to submit official comments to the Centers for Medicare & Medicaid Services (CMS) in support of direct and indirect remuneration (DIR) fee reform concepts described in the agency’s proposed rule, “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses.” The
WASHINGTON – The National Community Pharmacists Association, the National Association of Chain Drug Stores, and the National Association of Specialty Pharmacy issued the following statement regarding the Centers for Medicare & Medicaid Services’ (CMS) release on Monday of the proposed rule titled “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses”: “The
